AMICUS THERAPEUTICS, INC. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Amicus Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2024.
  • Amicus Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was $21.7M.
  • Amicus Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was $5.21M.
  • Amicus Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$77.2M, a 63.6% increase from 2022.
  • Amicus Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$212M, a 2.75% decline from 2021.
  • Amicus Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$206M, a 16.4% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $5.21M $21.7M +$38.7M Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 -$33.5M $15M +$33.8M Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$67.3M -$27.7M +$9.92M +26.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$77.2M -$3.69M +$38.6M +91.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 -$116M -$17M +$16.8M +49.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 -$133M -$18.9M +$41.8M +68.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$174M -$37.6M +$37.7M +50% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$212M -$42.3M +$29.8M +41.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 -$242M -$33.8M +$8.56M +20.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$250M -$60.6M -$21.8M -56.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$229M -$75.3M -$22.3M -42% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 -$206M -$72.1M -$7.31M -11.3% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 -$199M -$42.4M +$10.4M +19.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 -$209M -$38.8M +$12.5M +24.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$222M -$53.1M +$25M +32% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$247M -$64.8M +$24.2M +27.2% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 -$271M -$52.8M +$4.54M +7.93% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$276M -$51.3M +$25.1M +32.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$301M -$78.1M +$3.22M +3.96% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 -$304M -$89M -$19.5M -28.1% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 -$284M -$57.3M +$98.9M +63.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$383M -$76.4M -$29.5M -62.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$354M -$81.3M -$25.1M -44.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$329M -$69.5M -$1.81M -2.67% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 -$327M -$156M +$119M +43.3% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$446M -$46.9M +$130K +0.28% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 -$446M -$56.2M -$4.17M -8.01% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 -$442M -$67.7M -$22.3M -49% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-02
Q3 2017 -$420M -$275M -$230M -512% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-05
Q2 2017 -$189M -$47.1M +$1.48M +3.05% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 -$191M -$52M -$9.01M -21% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 -$182M -$45.4M -$4.02M -9.7% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 -$178M -$44.9M -$6.9M -18.1% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 -$171M -$48.5M -$21.6M -80.2% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 -$149M -$43M -$18.9M -78.7% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 -$130M -$41.4M -$19.4M -88.2% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-01
Q3 2015 -$111M -$38M -$21.2M -126% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 -$89.8M -$26.9M -$12.7M -88.9% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 -$77.1M -$24.1M -$8.44M -54% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-03
Q4 2014 -$68.7M -$22M -$6.21M -39.3% Oct 1, 2014 Dec 31, 2014 10-K/A 2017-03-03
Q3 2014 -$62.5M -$16.8M -$1.68M -11.1% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-04
Q2 2014 -$60.8M -$14.3M +$1.74M +10.9% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-05
Q1 2014 -$62.6M -$15.6M +$1.63M +9.45% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-05
Q4 2013 -$64.2M -$15.8M +$133K +0.84% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-29
Q3 2013 -$64.3M -$15.1M +$1.78M +10.5% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-06
Q2 2013 -$66.1M -$16M -$6.66M -71.2% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 -$59.4M -$17.3M -$6.51M -60.5% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-05
Q4 2012 -$52.9M -$15.9M -$2.89M -22.2% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-03
Q3 2012 -$50M -$16.9M -$3.78M -28.8% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 -$46.3M -$9.35M +$5.38M +36.5% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-07
Q1 2012 -$51.6M -$10.7M -$746K -7.46% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q4 2011 -$50.9M -$13M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-03
Q3 2011 -$13.1M +$131K +0.99% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-06
Q2 2011 -$14.7M -$2.04M -16.1% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-08
Q1 2011 -$10M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-11
Q3 2010 -$13.3M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-02
Q2 2010 -$12.7M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.